Medicine and Dentistry
Atrial Fibrillation
92%
Body Mass Index
10%
Cardiovascular System
19%
Electrocardiogram
8%
Heart Atrium Function
17%
Heart Failure
8%
Heart Failure with Preserved Ejection Fraction
8%
Paroxysmal Atrial Fibrillation
36%
Patient-Data
8%
Persistent Atrial Fibrillation
12%
Prevalence
9%
Quality of Life
9%
Rapid Amplification of cDNA Ends
25%
Sex Difference
8%
Targeted Therapy
9%
Keyphrases
Atrial Dysfunction
8%
Atrial Fibrillation
53%
Atrial Fibrillation Progression
29%
Atrial Function
8%
Body Mass Index
8%
Cardiovascular Outcomes
8%
Circulating Biomarkers
8%
Clinical Profile
8%
Clinical Utility
8%
Heart Failure
8%
Heart Failure with Preserved Ejection Fraction (HFpEF)
8%
Paroxysmal Atrial Fibrillation
16%
Persistent Atrial Fibrillation
11%
Progression Rate
10%
Quality of Life
9%
Sex Differences
11%
Targeted Therapy
9%
Young-onset
9%
Pharmacology, Toxicology and Pharmaceutical Science
Antiarrhythmic Agent
8%
Atrial Fibrillation
100%
Biological Marker
10%
Comorbidity
11%
Heart Failure
18%
Paroxysmal Atrial Fibrillation
36%
Persistent Atrial Fibrillation
20%
Prevalence
9%
